keyword
https://read.qxmd.com/read/37667230/cost-effectiveness-analysis-of-pembrolizumab-in-combination-with-chemotherapy-compared-with-chemotherapy-alone-as-first-line-treatment-for-patients-with-advanced-biliary-tract-cancer-in-china
#21
JOURNAL ARTICLE
Zhiwei Zheng, Ling Fang, Hongfu Cai
OBJECTIVE: The objective of this study is to evaluate the cost-effectiveness of adding pembrolizumab to the standard first-line therapy of advanced biliary tract cancer (BTC) with gemcitabine and cisplatin from the perspective of the Chinese healthcare system. METHODS: The partitioned survival model developed from clinical data obtained in The KEYNOTE-966 trial served as the basis for a simulation in the TreeAge Pro 2011 software. The objective of the research was to estimate the 10-year life expectancy and total healthcare costs of patients with BTC, utilizing primary outcomes that evaluated costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratio (ICER)...
September 4, 2023: BMC Cancer
https://read.qxmd.com/read/37665450/cost-utility-analysis-of-valsartan-enalapril-and-candesartan-in-patients-with-heart-failure-in-iran
#22
JOURNAL ARTICLE
Ramin Ravangard, Farideh Sadat Jalali, Marjan Hajahmadi, Abdosaleh Jafari
BACKGROUND: Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each year, and the prevalence of heart failure is expected to increase by 25%. One of the preventive interventions is pharmacological interventions which can be used to reduce the complications of cardiovascular diseases such as heart failure. One of the most important pharmacological interventions in patients with heart failure is the use of antihypertensive drugs such as candesartan, enalapril, and valsartan...
September 4, 2023: Health Economics Review
https://read.qxmd.com/read/37650903/surgical-correction-of-the-genital-hiatus-at-the-time-of-sacrocolpopexy-a-7-year-markov-analysis-a-cost-effectiveness-analysis
#23
JOURNAL ARTICLE
Olivia H Chang, Jonathan P Shepherd, Brad St Martin, Eric R Sokol, Shannon Wallace
INTRODUCTION AND HYPOTHESIS: To perform a cost-effectiveness analysis of concurrent posterior repair performed at the time of laparoscopic hysterectomy with sacrocolpopexy over a 7-year time period. We hypothesize it is not cost-effective to perform a posterior colporrhaphy. METHODS: We used TreeAge Pro® to construct a decision model with Markov modeling to compare sacrocolpopexy with and without concurrent posterior repair (SCP and SCP+PR) over a time horizon of 7 years...
August 31, 2023: International Urogynecology Journal
https://read.qxmd.com/read/37637281/cost-effectiveness-comparison-between-ticagrelor-and-clopidogrel-in-acute-coronary-syndrome-in-iran
#24
JOURNAL ARTICLE
Amir Hashemi-Meshkini, Amirmohammad Tajik, Nayyereh Ayati, Shekoufeh Nikfar, Reza Koochak, Saeed Yaghoubifard, Azam Abbasi, Mehdi Varmaghani
BACKGROUND: The present study aimed to determine the cost-effectiveness of ticagrelor compared with clopidogrel in Iranian patients with acute coronary syndrome (ACS). METHODS: A 1-year decision tree model combined with a 20-year Markov transition model was used to simulate the long-term cost and effectiveness of both ticagrelor and clopidogrel in Iran based on an Iranian payer's perspective. Clinical efficacy data were extracted from the PLATO trial and other published studies...
April 2023: Journal of Tehran Heart Center
https://read.qxmd.com/read/37608291/the-cost-effectiveness-of-intensity-modulated-radiation-therapy-and-three-dimensional-conformal-radiotherapy-in-the-treatment-of-head-and-neck-cancers
#25
JOURNAL ARTICLE
Mehdi Varmaghani, Malihe Amiri, Hossein Ebrahimpour, Roham Salek, Javad Javan-Noughabi
PURPOSE: Intensity-modulated radiotherapy is developed as a replacement for 3-dimensional conformal radiation therapy. Considering the difference in costs and effectiveness of these interventions, the aim of this study was to compare the cost effectiveness of intensity-modulated radiation therapy and three-dimensional conformal radiotherapy in the treatment of head and neck cancer in east of Iran. METHODS: A Markov model including six states based on xerostomia and dysphagia was developed to estimate the incremental cost effectiveness ratio from the perspective of societal...
August 22, 2023: Radiation Oncology
https://read.qxmd.com/read/37580701/cost-effectiveness-analysis-of-diagnostic-strategies-for-covid-19-in-iran
#26
JOURNAL ARTICLE
F Rahmanzadeh, N Malekpour, A Faramarzi, H Yusefzadeh
BACKGROUND: Since 2020, COVID-19 has become a global public health issue and has caused problems worldwide. This infection can lead to a fever and respiratory problems. Asymptomatic carriers of the virus are a significant part of the spread of the disease, so early screening and diagnosis of suspected cases of COVID-19 are essential. Generally, standard diagnostic methods include lung imaging (CT), polymerase chain reaction (PCR), and corona antibody (IgM&IgG) testing. However, the costs of the above tests for the healthcare system cannot be ignored, and evaluating the incremental costs against the additional benefit is necessary...
August 14, 2023: BMC Health Services Research
https://read.qxmd.com/read/37554067/cost-effectiveness-analysis-of-regenerative-endodontics-versus-mta-apexification
#27
JOURNAL ARTICLE
N Naved, F Umer, A R Khowaja
INTRODUCTION: With the introduction of stem cell engineering in dentistry, regenerative endodontics has emerged as a potential alternative to mineral trioxide aggregate (MTA) apexification in the management of necrotic immature permanent teeth. However, the utility of this modality in terms of cost-effectiveness has not yet been established. Therefore, we performed cost-effectiveness analysis to determine the dominant treatment modality that would influence decision making from the private payer perspective...
August 9, 2023: JDR Clinical and Translational Research
https://read.qxmd.com/read/37531348/community-based-transport-system-in-shinyanga-tanzania-a-local-innovation-averting-delays-to-access-health-care-for-maternal-emergencies
#28
JOURNAL ARTICLE
Castory Munishi, Gilbert Mateshi, Linda B Mlunde, Belinda J Njiro, Jackline E Ngowi, James T Kengia, Ntuli A Kapologwe, Linda Deng, Alice Timbrell, Wilson Kitinya, Andrea B Pembe, Bruno F Sunguya
In achieving the sustainable development goal 3.1, Tanzania needs substantial investment to address the three delays which responsible for most of maternal deaths. To this end, the government of Tanzania piloted a community-based emergency transport intervention to address the second delay through m-mama program. This study examined secondary data to determine the cost-effectiveness of this intervention in comparison to the standard ambulance system alone. The m-mama program was implemented in six councils of Shinyanga region...
2023: PLOS Glob Public Health
https://read.qxmd.com/read/37474906/is-vitamin-d-supplementation-program-in-iranian-schools-effective-in-reducing-adolescent-depressive-symptoms-cost-effectiveness-study
#29
JOURNAL ARTICLE
Seyed Vahid Jasemi, Zhale Zandieh, Narges Zandieh, Mohsen Rezaei Hemami, Ali Darvishi, Zahra Abdollahi, Ramin Heshmat
PURPOSE: We aimed to assess the cost-effectiveness of the vitamin D supplementation program in Iranian adolescents reducing adolescent depressive Symptoms. METHODS: In the current cost-effectiveness analysis, the viewpoint of Iran's Ministry of Health was selected. The target population was 1,519,762 Iranian high school students (733,657 girls and 786,105 boys). The total costs of the vitamin D supplementations program were based on the reports of the Nutrition Improvement Office of Iran's Ministry of Health and were adjusted to 2018...
July 20, 2023: BMC Public Health
https://read.qxmd.com/read/37423791/cost-analysis-for-mirabegron-use-in-the-treatment-of-children-with-neurogenic-bladder
#30
JOURNAL ARTICLE
Rena Xu, Andrea Balthazar, Rebecca Sherlock, Carlos Estrada
INTRODUCTION: Mirabegron is a beta-3 adrenergic receptor agonist that received FDA approval in 2021 to treat neurogenic detrusor overactivity (NDO) in children ages three years and older. Despite its safety and efficacy, access to mirabegron frequently remains restricted by payor coverage policies. OBJECTIVE: This cost minimization study sought to determine the cost implications from a payor perspective of mirabegron use at different points in the treatment pathway for pediatric NDO...
June 14, 2023: Journal of Pediatric Urology
https://read.qxmd.com/read/37384744/cost-effectiveness-of-mechanical-thromboprophylaxis-for-cesarean-deliveries-in-brazil
#31
JOURNAL ARTICLE
Alex Veloz, Ubong Silas, Rhodri Saunders, Jody Grisamore, André Luiz Malavasi
OBJECTIVE: To evaluate the cost-effectiveness of using mechanical thromboprophylaxis for patients undergoing a cesarean delivery in Brazil. METHODS: A decision-analytic model built in TreeAge software was used to compare the cost and effectiveness of intermittent pneumatic compression to prophylaxis with low-molecular-weight heparin or no prophylaxis from the perspective of the hospital. Related adverse events were venous thromboembolism, minor bleeding, and major bleeding...
2023: PloS One
https://read.qxmd.com/read/37330122/preventing-eviction-during-pregnancy-a-cost-effectiveness-analysis-of-a-theoretical-safety-net-program
#32
JOURNAL ARTICLE
Ava Mandelbaum, Sarah Dzubay, Sarina R Chaiken, Uma Doshi, Isabel Katlaps, Aaron B Caughey
BACKGROUND: Eviction during pregnancy has been shown to be associated with adverse birth outcomes. A safety net program focused on covering the costs of rent during pregnancy may aid in preventing adverse complications. OBJECTIVE: This study aimed to evaluate the cost-effectiveness of a program covering the cost of rent to prevent eviction during pregnancy. STUDY DESIGN: A cost-effectiveness model using TreeAge software was designed to evaluate the cost, effectiveness, and incremental cost-effectiveness ratio associated with eviction compared to no eviction during pregnancy...
June 15, 2023: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/37314727/cost-effectiveness-of-folfox6-bevacizumab-versus-folfox6-cetuximab-in-stage-iv-colorectal-cancer-patients-in-shiraz-iran
#33
JOURNAL ARTICLE
Abdosaleh Jafari, Sedighe Sadat Tabatabaei Far, Mehdi Dehghani, Ramin Ravangard
BACKGROUND: Colorectal cancer is one of the most common cancers in the world, with about one million cases diagnosed annually. Various treatment methods can be used to treat colorectal cancer, including chemotherapy with different drug regimens. Considering the need to opt for more effective and less expensive drugs in the treatment of this disease, the present study aimed to compare the cost-effectiveness of FOLFOX6+Bevacizumab with FOLFOX6+Cetuximab in patients with stage IV colorectal cancer referred to medical centers in Shiraz, Iran, in 2021...
2023: Cancer Control: Journal of the Moffitt Cancer Center
https://read.qxmd.com/read/37178027/graft-subsidence-and-reoperation-after-lateral-lumbar-interbody-fusion-a-propensity-score-matched-and-cost-analysis-of-polyetheretherketone-versus-3d-printed-porous-titanium-interbodies
#34
JOURNAL ARTICLE
Nima Alan, Hansen Deng, Nallammai Muthiah, Lena Vodovotz, Robert Dembinski, Daipayan Guha, Nitin Agarwal, Alp Ozpinar, D Kojo Hamilton, Adam S Kanter, David O Okonkwo
OBJECTIVE: Lumbar interbody cage subsidence has a multifactorial etiology. Cage material, although well studied after transforaminal lumbar interbody fusion, has not been investigated as a contributing factor to subsidence after lateral lumbar interbody fusion (LLIF). In this study the authors compared rates of subsidence and reoperation after LLIF between polyetheretherketone (PEEK) and 3D-printed porous titanium (pTi) in an institutional propensity score-matched and cost analysis. METHODS: This is a retrospective observational cohort analysis of adult patients who underwent LLIF with pTi versus PEEK between 2016 and 2020...
May 12, 2023: Journal of Neurosurgery. Spine
https://read.qxmd.com/read/37143011/cost-effectiveness-analysis-of-sarcopenia-management-interventions-in-iran
#35
JOURNAL ARTICLE
Ali Darvishi, Gita Shafiee, Narges Zargar Balajam, Mohsen Rezaei Hemami, Navid Ostovar, Ramin Heshmat
OBJECTIVES: Identification the optimal management intervention of sarcopenia is a concern of health systems. We aimed to analyze the cost-effectiveness of sarcopenia management strategies in Iran. METHODS: We constructed a lifetime Markov model based on natural history. The strategies comparedincluded exercise training, nutritional supplements, whole body vibration (WBV), and various exercise interventions and nutritional supplement combinations. A total of 7 strategies was evaluated in addition to the non-intervention strategy...
May 4, 2023: BMC Public Health
https://read.qxmd.com/read/37037370/mechanical-thrombectomy-versus-best-medical-management-for-acute-ischemic-stroke-in-elderly-patients-a-cost-effectiveness-analysis
#36
JOURNAL ARTICLE
Jaims Lim, Andre Monteiro, Nicco Ruggiero, Ammad A Baig, Alexander O Aguirre, Matthew J McPheeters, Muhammad Waqas, Kunal Vakharia, Kenneth V Snyder, Adnan H Siddiqui, Elad I Levy, Jason M Davies
OBJECTIVE: To determine the cost-effectiveness of mechanical thrombectomy (MT) versus best medical management (BMM) in patients ≥80 years. METHODS: We performed a systematic literature review to identify comparative studies of MT vs BMM with or without intravenous tissue-type plasminogen activator (IV tPA) in patients ≥80 years. Clinical data including outcomes and mortality categorized as modified Rankin scale (mRS) scores 0-2, 3-5, and 6 were collected from identified studies, and effectiveness scores were assigned to each outcome...
April 8, 2023: World Neurosurgery
https://read.qxmd.com/read/37030073/ovarian-preservation-compared-to-oophorectomy-in-premenopausal-women-with-early-stage-low-grade-endometrial-cancer-a-cost-effectiveness-analysis
#37
JOURNAL ARTICLE
Miriam L Hernandez-Zepeda, Elizabeth G Munro, Aaron B Caughey, Amanda S Bruegl
OBJECTIVES: Standard treatment for endometrial cancer is a hysterectomy, bilateral salpingo-oophorectomy, and lymph node assessment. In premenopausal women, removal of the ovaries may not be necessary and could increase the risk of all-cause mortality. We sought to estimate the outcomes, costs, and cost-effectiveness of oophorectomy versus ovarian preservation in premenopausal women with early-stage, low-grade endometrial cancer. METHODS: A decision-analytic model was designed using TreeAge software comparing oophorectomy to ovarian preservation in premenopausal women with early-stage, low-grade endometrial cancer...
June 2023: Gynecologic Oncology
https://read.qxmd.com/read/37004046/cost-effectiveness-analysis-of-sorafenib-lenvatinib-atezolizumab-plus-bevacizumab-and-sintilimab-plus-bevacizumab-for-the-treatment-of-advanced-hepatocellular-carcinoma-in-china
#38
JOURNAL ARTICLE
Hongyu Gong, Siew Chin Ong, Fan Li, Zhiying Weng, Keying Zhao, Zhengyou Jiang
BACKGROUND AND OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide, especially in China. According to the 2021 Chinese Society of Clinical Oncology guidelines, sorafenib, lenvatinib, atezolizumab combined with bevacizumab, and sintilimab combined with bevacizumab are recommended as first-line treatment options for advanced HCC. This study provides a cost-effectiveness analysis of these treatments from the patient perspective. METHODS: A partitioned survival model was established using the TreeAge 2019 software to evaluate the cost-effectiveness...
March 31, 2023: Cost Effectiveness and Resource Allocation: C/E
https://read.qxmd.com/read/36995850/cost-effectiveness-analysis-of-the-treatment-with-compressive-therapy-in-the-healing-of-venous-ulcers
#39
JOURNAL ARTICLE
Sarah Lopes Silva Sodré, Glycia de Almeida Nogueira, Alcione Matos de Abreu, Cristiano Bertolossi Marta, Antônio Augusto de Freitas Peregrino, Roberto Carlos Lyra da Silva
OBJECTIVE: to analyze the cost-effectiveness and calculate the incremental cost-effectiveness ratio of multilayer compressive treatment in relation to inelastic (Unna boot and short stretch) therapy according to the current literature. METHOD: quantitative study about cost-effectiveness through modeling with the aid of TreeAge® software for construction of the decision tree. The anticipated assumptions were obtained by using secondary literature data to estimate the cost and effectiveness of the assumed parameters...
March 27, 2023: Revista Latino-americana de Enfermagem
https://read.qxmd.com/read/36974460/cost-effectiveness-of-a-new-aci-technique-for-the-treatment-of-articular-cartilage-defects-of-the-knee-compared-to-regularly-used-aci-technique-and-microfracture
#40
JOURNAL ARTICLE
Martyn Snow, Vipul Mandalia, Roel Custers, Pieter J Emans, Elizaveta Kon, Philipp Niemeyer, René Verdonk, Christoph Gaissmaier, André Roeder, Sina Weinand, York Zöllner, Tino Schubert
AIMS: For patients with cartilage defects of the knee, a new biocompatible and in situ cross-linkable albumin-hyaluronan-based hydrogel has been developed for matrix-associated autologous chondrocyte implantation (M-ACI) - NOVOCART® Inject plus (NInject)1. We aimed to estimate the potential cost-effectiveness of NInject, that is not available on the market, yet compared to spheroids of human autologous matrix-associated chondrocytes (Spherox® )2 and microfracture. MATERIALS AND METHODS: An early Markov model was developed to estimate the cost-effectiveness in the United Kingdom (UK) from the payer perspective...
March 28, 2023: Journal of Medical Economics
keyword
keyword
24878
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.